Science, innovation and commitment

We have received ISO 56001 certification after successfully passing the external audit by AENOR.

We have reached a new milestone in our commitment to excellence in research and innovation management after successfully passing the external audit conducted by AENOR to obtain ISO 56001 certification, the international benchmark standard for innovation management systems.

News

Sant Joan de Déu nominated for the Prix Galien USA 2026 Patient First Award

The Sant Joan de Déu Private Foundation for Research and Teaching (FSJD) has been nominated for the Prix Galien USA 2026 Patient First Award, an international award recognising initiatives that incorporate the patient perspective into clinical research and clinical trials.

IRSJD Leads the Pediatric Cancer Use Case of the European UNCAN-Connect Project

Sant Joan de Déu is laying the groundwork for a new algorithm to anticipate the risk of cardiotoxicity linked to cancer treatment, helping improve the quality of life of children and adolescents with cancer.

A study identifies the key role of a protein and paves the way for new therapeutic strategies.

A study identifies the key role of a protein and opens the way to new therapeutic strategies.

Agenda

ImmunoPET: Bridging Molecular Imaging and Targeted Therapy

IRSJD November Scientific Seminar: "ImmunoPET: Bridging Molecular Imaging and Targeted Therapy". Raul Herance Camacho (VHIR).

Auditori Plaza HSJD

15h

V Jornada Científica del IRSJD

We are pleased to announce the 5th IRSJD Scientific Symposium, which will take place on December 17, 2026, at the Auditorium of the Parc Sanitari Sant Joan de Déu.

Auditori del Parc Sanitari Sant Joan de Déu

8:15h

Interviews

Daniel Natera

Researcher in applied research on neuromuscular diseases

"A question in the consultation room can become an answer for children around the world"

Read more More Interviews